Your browser doesn't support javascript.
loading
Preoperative chronic steroid use as a risk factor for complications following open reduction internal fixation for proximal humerus fracture.
Smolev, Emma; Lebens, Ryan; Leatherwood, William; Kennedy, John; Komatsu, David E; Wang, Edward D.
Afiliação
  • Smolev E; Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA. Emma.Smolev@stonybrookmedicine.edu.
  • Lebens R; Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA.
  • Leatherwood W; Department of Orthopaedics and Rehabilitation, Stony Brook University, Stony Brook, NY, USA.
  • Kennedy J; Department of Orthopaedics and Rehabilitation, Stony Brook University, Stony Brook, NY, USA.
  • Komatsu DE; Department of Orthopaedics and Rehabilitation, Stony Brook University, Stony Brook, NY, USA.
  • Wang ED; Department of Orthopaedics and Rehabilitation, Stony Brook University, Stony Brook, NY, USA.
Article em En | MEDLINE | ID: mdl-39046490
ABSTRACT

PURPOSE:

The primary objective of this study was to investigate the association between preoperative chronic steroid use and postoperative complications following open reduction internal fixation (ORIF) for proximal humerus fractures (PHF).

METHODS:

The American College of Surgeons National Surgical Quality Improvement (ACS-NSQIP) database was queried for all patients who underwent PHF ORIF between 2015 and 2021. A total of 6,273 patients were included in this study, of which 3.4% (n = 212) were in the chronic steroid use cohort. Patient characteristics including demographics, comorbidities, and 30-day postoperative complications after PHF ORIF were collected. Bivariate logistic regression and multivariate logistic regression analysis, adjusted for all significantly associated variables, was conducted to investigate the relationship between preoperative chronic steroid use and postoperative complications.

RESULTS:

Chronic steroid use was significantly associated with age ≥ 75 (p < 0.001), male gender (p =0.006), dependent functional status (p = 0.008), American Society of Anesthesiologist (ASA) ≥ 3 (p < 0.001), CHF (p = 0.007), hypertension (p < 0.001), COPD (p < 0.001), bleeding disorder (p = 0.007), ascites (p = 0.040), disseminated cancer (p< 0.001), and systemic sepsis (p < 0.001). After adjusting for all significantly associated variables, chronic steroid use was independently associated with major complication (OR 1.60, 95% CI 1.06-2.43; p = 0.026), and non-home discharge (OR 1.05, 95% CI 1.01-1.08; p = 0.014).

CONCLUSION:

Preoperative chronic steroid use is associated with increasing rate of postoperative complications following PHF ORIF. Better understanding and characterizing chronic steroid use as a preoperative risk factor can aid physicians in risk stratification to reduce rates of postoperative complications following PHF ORIF. LEVEL OF EVIDENCE III. Retrospective Cohort Comparison; Prognosis Study.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Orthop Surg Traumatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Orthop Surg Traumatol Ano de publicação: 2024 Tipo de documento: Article